Chrono Therapeutics snags $32 mln Series A
Digital drug products provider Chrono Therapeutics has closed $32 million in Series A financing. Canaan Partners and 5AM Ventures led the round with participation from Fountain Healthcare Partners, Mayo Clinic and GE Ventures. In conjunction with the funding, Wende Hutton, general partner at Canaan Partners, Jim Young of 5AM Ventures and Aidan King of Fountain, have been named to Chrono's board of directors.
13 June 2014•3 mins read
